Release and diffusional modeling of metronidazole lipid matrices

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 63, Issue 3, 2006, Pages 331-339

  Özyazici, Mine ^a   Gökçe, Evren H ^a   Ertan, Gökhan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Controlled release; Diffusion mechanism; Lipid matrix; Metronidazole; Swelling

Indexed keywords

GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; HYDROGENATED CASTOR OIL; LIPID; METRONIDAZOLE; PROPOLIS; STEARIC ACID; UNCLASSIFIED DRUG; WAX;

ARTICLE; CARNAUBA WAX; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG DIFFUSION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; EROSION; IN VITRO STUDY; LIPOPHILICITY; MEDICAL LITERATURE; PARTICLE SIZE; POWDER; SWELLING; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; LIPIDS; METRONIDAZOLE; PARTICLE SIZE; SOLUBILITY; TABLETS; WAXES;

EID: 33747103488     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.02.005     Document Type: Article

References (39)

1. Campos-Aldrete M.E., and Villafuerte-Robles L. Influence of the viscosity grade and particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm. 43 (1997) 173-178
2. Savolainen M., Khoo C., Glad H., Dahlqvist C., and Juppo A.M. Evaluation of controlled-release polar lipid microparticles. Int. J. Pharm. 244 (2002) 151-161
3. Zhang Y., and Schwartz J.B. Melt granulation and heat treatment for wax matrix-controlled drug release. Drug Dev. Ind. Pharm. 29 (2003) 131-138
4. Liu J., Zhang F., and McGinity J.W. Properties of lipophobic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur. J. Pharm. Biopharm. 52 (2001) 181-190
5. Otsuka M., and Matsuda Y. Effect of cogrinding time on the release of pentoxyfylline from waxy matrix tablets. J. Pharm. Sci. 83 (1994) 956-961
6. Sato H., Miyagawa Y., Okabe T., Miyajima M., and Sunada H. Dissolution mechanism of diclofenac sodium from wax matrix granules. J. Pharm. Sci. 86 (1997) 929-934
7. Obaidat A.A., and Obaidat R.M. Controlled-release of tramadol hydrochloride from matrices prepared using glyceryl behenate. Eur. J. Pharm. Biopharm. 52 (2001) 231-235
8. Hörter D., and Dressman J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 46 (2001) 75-87
9. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52 (1963) 1145-1149
10. Schwartz B.J., Simonelli A.P., and Higuchi W.I. Drug release from wax matrices I; Analysis of data with first-order kinetics and with the diffusion-controlled model. J. Pharm. Sci. 57 (1968) 274-277
11. Cobby J., Mayersohn M., and Walker G.C. Influence of shape factors on kinetics of drug release from matrix tablets I: theoretical. J. Pharm. Sci. 63 (1974) 725-732
12. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48 (2001) 139-157
13. Golomb G., and Fisher P. The relationship between drug release rate, particle size and swelling of silicone matrices. J. Control. Rel. 12 (1990) 121-132
14. Miyagawa Y., Okabe T., Yamaguchi Y., Miyajima M., Sato H., and Sunada H. Controlled-release of diclofenac sodium from wax matrix granule. Int. J. Pharm. 138 (1996) 215-224
15. Chang C.M., and Bodmeier R. Swelling of and drug release from monoglyceride-based drug delivery systems. J. Pharm. Sci. 86 (1997) 747-752
16. Genç L., Bilaç H., and Güler E. Studies on controlled release dimenhydrinate from matrix tablet formulations. Pharm. Acta Helv. 74 (1999) 43-49
17. United States Pharmacopeial Convention Inc, The United States Pharmacopeia 24, The National Formulary 19, Rockville, MD, 2000, pp. 1941-1943.
18. M.A. Ege, H.Y. Karasulu, E. Karasulu, G. Ertan, A computer program designed for in vitro dissolution kinetics, in vitro-in vivo kinetic correlations and routine applications, in: 4th Central European Symposium on Pharmaceutical Technology, 23-25 September, Vienna, 2001, Sci. Pharm. 69 (3). .
19. Ozguney I., Ertan G., and Guneri T. Dissolution characteristics of megaloporous tablets prepared with two kinds of matrix granules. Il Farmaco 59 (2004) 549-555
20. Robinson J.R., and Eriksen S.P. Theoretical formulation of sustained release dosage forms. J. Pharm. Sci. 55 (1966) 1254-1263
21. Cusimano A.G., and Becker C.H. Spray-congealed formulations of sulfaethylthiadiazole (SETD) and waxes for prolonged-release medication; effect of Wax. J. Pharm. Sci. 57 (1968) 1104-1112
22. Evrard B., and Delattre L. In vitro evaluation of lipid matrices for the development of a sustained-release sulfamethazine bolus for lambs. Drug Dev. Ind. Pharm. 22 (1996) 111-118
23. Shellhammer T.H., Rumsey T.R., and Krochta J.M. Viscoelastic properties of edible lipids. J. Food Eng. 33 (1997) 305-320
24. Akiyama Y., Yoshioka M., Horibe H., Hirai S., Kitamori N., and Toguchi H. Novel oral controlled-release microspheres using polyglycerol esters of fatty acids. J. Control. Rel. 26 (1993) 1-10
25. Rodriguez L., Passerini N., Cavallari C., Cini M., Sancin P., and Fini A. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int. J. Pharm. 183 (1999) 133-143
26. Boylan J.C. Handbook of Pharmaceutical Excipients (1986), American Pharmaceutical Association, Washington, USA pp. 49-50, 298-299, 339-340, 344-345
27. Hamdani J., Moes A.J., and Amighi K. Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int. J. Pharm. 260 (2003) 47-57
28. Reynolds J.E.F. Martindale, The Extra Pharmacopoeia. 32nd ed. (1999), Pharmaceutical Press, London pp. 758-761
29. Parab P.V., Oh C.K., and Ritschel W.A. Sustained release from Precirol (Glycerol palmito stearate) matrix. Effect of mannitol and hydroxypropylmethylcellulose on the release of theophylline. Drug Dev. Ind. Pharm. 12 (1986) 1309-1327
30. Saraiya D., and Bolton S. The use of Precirol to prepare sustained release tablets of theophylline and quinidine gluconate. Drug Dev. Ind. Pharm. 16 (1990) 1963-1969
31. Roseman T.J., and Higuchi W.I. Release of medroxyprogesterone acetate from a silicone polymer. J. Pharm. Sci. 59 (1970) 353-357
32. Lee P.I. Kinetics of drug release from hydrogel matrices. J. Control. Rel. 2 (1985) 277-288
33. Mandal T.K. Swelling-controlled release system for the vaginal delivery of miconazole. Eur. J. Pharm. Biopharm. 50 (2000) 337-343
34. Peppas N.A., and Sahlin J.J. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 57 (1989) 169-172
35. Shanawany S.E. Sustained release of nitrofurantoin from inert wax matrixes. J. Control. Rel. 26 (1993) 11-19
36. Lindenbaum S. In: Swarbrick J., and Boylan J.C. (Eds). Calorimetry in Pharmaceutical Research and Development in Encyclopedia of Pharmaceutical Technology vol. 2 (1990), Marcel Dekker Inc., New York 233-250
37. Ford J.L., and Timmins P. Pharmaceutical Thermal Analysis: Technic and Applications (1989), E. Hozwood, Chichester 238-247 chapter 10
38. Zahao X., Wang X.H., and Yan J. Water-swelling behaviour of hydrophobic porous copolymer resins composed of two kinds of crosslinkers. J. Appl. Polymer Sci. 92 (2004) 997-1004
39. Meshali M.M., El-Sayed G.M., El-Aleem H.M.A., and El-Said Y. Optimisation of theophylline release from tablets containing Compritol. S.T.P. Pharma Sci. 5 (1995) 429-434